
亚太地区血糖监测设备市场预测至 2030 年 - 区域分析 - 按类型(连续血糖监测设备和自我血糖监测设备)、应用(1 型糖尿病和 2 型糖尿病)、测试类型(指尖测试和替代站点测试)、和最终用户(医疗保健设置和自我/家庭护理)
No. of Pages: 107 | Report Code: BMIRE00029112 | Category: Life Sciences
No. of Pages: 107 | Report Code: BMIRE00029112 | Category: Life Sciences
老年人口的糖尿病是全球日益严重的公共卫生负担。它是老龄化人口发病和死亡的主要原因,后来主要归因于各种慢性并发症。人口老龄化将成为最重大的变革之一,对全球社会和经济水平产生重大影响。这一人口在全球范围内呈指数级增长。根据世界卫生组织(2022)的数据,到 2030 年,每 6 人中就有 1 人年龄在 60 岁或以上。 60岁及以上人口比例将从2020年的10亿增加到14亿。到 2050 年,世界 60 岁及以上人口将增加一倍(21 亿)。 2020 年至 2050 年间,80 岁或以上的人口数量预计将增加两倍,达到 4.26 亿。非洲老年人口数量预计将显着增长,其次是亚太地区。老年人比年轻人更容易患糖尿病,这种疾病对这一人群生活质量的影响尤其严重。随着老年人口的增加,糖尿病的患病率也随之增加。因此,对血糖监测设备的需求显着。
亚太地区血糖监测设备市场已细分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。中国市场的增长很大程度上归功于糖尿病诊断意识的不断提高。由于印度糖尿病患病率很高,因此在连续血糖监测方面占有第二大份额。上述因素影响了亚太地区血糖监测设备市场的增长。
亚太地区血糖监测设备市场细分为类型、应用、测试地点、最终用户、和国家。
根据类型,亚太地区血糖监测设备市场分为连续血糖监测设备和自我血糖监测设备。 2022年,自我血糖监测设备细分市场在亚太地区血糖监测设备市场中占据较大份额。
根据应用,亚太地区血糖监测设备市场分为1型糖尿病和2型糖尿病。 2022年,2型糖尿病细分市场在亚太地区血糖监测设备市场中占据较大份额。
根据测试地点,亚太地区血糖监测设备市场分为指尖测试和替代地点测试。 2022年,指尖测试细分市场在亚太地区血糖监测设备市场中占据较大份额。
根据最终用户,亚太地区血糖监测设备市场分为医疗保健环境和自我/家庭护理。 2022 年,自我/家庭护理细分市场在亚太地区血糖监测设备市场中占据较大份额。
按国家/地区划分,亚太地区血糖监测设备市场分为中国、印度、日本、韩国、澳大利亚和亚太地区其他地区。 2022 年,中国将主导亚太地区血糖监测设备市场。
B. Braun SE、F. Hoffmann-La Roche Ltd、Medtronic Plc、Abbott Laboratories、Ypsomed Holding AG、Nipro Corp、GE HealthCare Technologies Inc 和 Terumo Corp 是亚太地区血糖监测设备市场的一些领先公司。
Strategic insights for Asia Pacific Glucose Monitoring Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 3,386.90 Million |
Market Size by 2030 | US$ 8,471.46 Million |
Global CAGR (2022 - 2030) | 12.1% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Glucose Monitoring Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Glucose Monitoring Devices Market is valued at US$ 3,386.90 Million in 2022, it is projected to reach US$ 8,471.46 Million by 2030.
As per our report Asia Pacific Glucose Monitoring Devices Market, the market size is valued at US$ 3,386.90 Million in 2022, projecting it to reach US$ 8,471.46 Million by 2030. This translates to a CAGR of approximately 12.1% during the forecast period.
The Asia Pacific Glucose Monitoring Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Glucose Monitoring Devices Market report:
The Asia Pacific Glucose Monitoring Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Glucose Monitoring Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Glucose Monitoring Devices Market value chain can benefit from the information contained in a comprehensive market report.